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ScienceDirectHomeodomain proteins are evolutionary conserved proteins
present in the entire eukaryote kingdom. They execute
functions that are essential for life, both in developing and adult
organisms. Most homeodomain proteins act as transcription
factors and bind DNA to control the activity of other genes. In
contrast to their similar DNA binding specificity, homeodomain
proteins execute highly diverse and context-dependent
functions. Several factors, including genome accessibility, DNA
shape, combinatorial binding and the ability to interact with
many transcriptional partners, diversify the activity of
homeodomain proteins and culminate in the activation of highly
dynamic, context-specific transcriptional programs. Clarifying
how homeodomain transcription factors work is central to our
understanding of development, disease and evolution.
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Introduction
Homeodomain (HD) proteins are transcription factors
(TFs) present in the entire eukaryote kingdom, from
unicellular organisms, to plants, fungi and animals [1].
HD TFs represent about 15–30% of all TFs in plants and
animals, acting in all tissues of the embryo and the adult
organism to regulate processes as diverse as axis pattern-
ing [2], stem cell maintenance [3] or metabolic responses
[4,5]. The HD refers to the DNA-binding region, which is
typically 60 amino acids long and contains a helix-turn-
helix (HTH) motif. Because of this feature, HD proteins
are identified as DNA binding TFs, that is, TFs that
recognize specific DNA sequences to access their targetwww.sciencedirect.com genes in the genome, and to control their expression. The
molecular mechanisms employed by HD proteins to
regulate transcription are still poorly understood. A cen-
tral issue is how HD TFs select their target genes in the
genome using a DNA binding domain with limited se-
quence specificity, which basically recognizes short (four
to six nucleotides), AT-rich sequences. Next generation
sequencing based approaches (-seq) have changed our
general understanding of how TFs regulate gene expres-
sion in vivo. Here we integrate these new findings with
the most recent observations on the molecular cues that
guide HD TFs DNA-binding site recognition and cofac-
tor interactions. Our survey highlights a striking variety of
strategies employed by HD proteins to access their ge-
nomic sites and control transcription.
Accessing functional target sites in the
genome
Transcriptional regulation is highly dependent on the
binding of TFs to specific DNA binding motifs [6,7].
However, the properties that determine HD TFs DNA
binding specificity are still not clear. HD proteins recog-
nize short and relatively similar AT rich sequences in
vitro; for instance, despite controlling diverse biological
processes, HD proteins encoded by ANTP-like homeo-
box genes (46% of Drosophila HD TFs) recognize the
same high-affinity binding sites [8,9]. Notably, genome-
wide occupancy data reveal a wide discrepancy between
predicted and observed binding of TFs. The vast majori-
ty of consensus motifs found in the genome are not bound
by the respective TF [10]. It is therefore clear that the
presence of a binding motif per se is not sufficient for
directing TFs to their target sites in the genome
(Figure 1). What else contributes? DNA–TF interactions
in vivo are largely shaped by the chromatin landscape.
Nucleosomes, the core organization of chromatin, provide
a hindrance to most TFs binding. While a handful of TFs,
termed pioneer TFs, can actively open condensed chro-
matin [11], most TFs appear to preferentially bind to
regions of open, accessible chromatin [12,13]. In addition
to nucleosomes, the distribution of sequence-specific
TFs (cell-specific and tissue-specific, but also ubiquitous)
greatly affects TFs binding. High-throughput analysis of
TFs binding to DNA shows a widespread ability of TFs
to bind cooperatively with themselves and DNA, and to
recognize composite DNA sites, which can be markedly
different from the DNA recognition sites of each TF
[14]. Although these observations largely derive from
studies on TFs that are not HD proteins, they are in
general agreement with available information on HD TFsCurrent Opinion in Genetics & Development 2017, 43:1–8
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Binding specificity of homeodomain (HD) transcription factors (TFs). In
vitro, different HD proteins preferentially recognize similar AT rich
sequences with high affinity. In vivo, the DNA-binding specificity is
modulated by additional factors, including chromatin structure (which
influences accessibility to the DNA-binding site), chromatin landscape
(presence of other TFs that can positively or negatively affect binding
of the HD protein), and the shape of the DNA double helix (a key
biochemical feature of the DNA-binding site recognized by HD
proteins, in addition to the nucleotide sequence). Together, these
molecular features result in the recognition of lower affinity DNA-
binding sites by HD TFs and contribute to the activation of specific
transcriptional programs in vivo. Asterisk denotes histones post-
translational modifications in nucleosomes (grey circles). HD,
homeodomain; TF, transcription factor.
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ing of Hox Deformed (Dfd) and Ultrabithorax (Ubx) at
identical developmental stages in Drosophila, shows that
Dfd and Ubx interact with non-overlapping genomic
regions and are associated with distinct classes of genes,
despite recognizing identical DNA motifs in vivo [15].
Hox proteins can bind cooperatively with three amino
acid loop extension (TALE) HD TFs Extradenticle
(Exd)/Pbx and Homothorax (Hth)/Meis in vitro [16]. In
the branchial arches (mouse) Pbx and Meis provide an
accessible chromatin platform for Hoxa2 to bind [17]. In
turn, Hoxa2 operates as a tissue-specific cofactor and
enhances Meis binding to specific genomic sites (contain-
ing closely arranged Meis and Hox motifs) [18]. In the
Drosophila haltere disc, binding of the Hox protein Ultra-
bithorax (Ubx) largely overlaps binding of Hth [19].
When overexpressed, Ubx can target its specific regions
in the absence of Hth, but adding Hth targets Ubx to
inaccessible chromatin and increases the number of Ubx
bound sites [20]. The HD protein NKX2-5, an essential
regulator of heart development, occupies largely over-
lapping genomic sites with TBX5 and the zinc finger TF
GATA4 in differentiating cardiomyocytes [21]. NKX2-
5, TBX5 and GATA4 combinatorial binding depends on
chromatin accessibility and closely arranged binding sites.
Shared genomic occupancy coincides with active enhan-
cers that control the expression of cardiac-specific genes.
In sum, direct or indirect interactions shape the genomic
distribution of HD TFs.
The above examples reflect a positive effect of combina-
torial binding, both on the number of binding sites
occupied by HD TFs and on their level of binding.
Intriguingly, combinatorial DNA binding serves also
the purpose to prevent TFs from redistributing to ectopic
genomic sites and activate lineage-inappropriate genes
[21]. Similarly, in the secondary heart field, binding of
Meis and NKX2-5 to closely spaced recognition motifs is
mutually exclusive, and prevents NKX2-5 from accessing
a pool of its targets in inappropriate embryonic areas/
stages of development [22]. In addition, mutations in
NKX2-5, found in congenital heart disease, modify
NKX2-5 partners interaction and result in the redistribu-
tion of NKX2-5 to a different set of genomic sites [23].
Therefore combinatorial interactions and also competi-
tive inhibition of binding at those DNA recognition sites
occupied by other sequence-specific factors prevent HD
TFs from redistributing across the genome. These in-
creasingly common observations highlight that HD TFs
genomic binding is highly context dependent, and is cell-
specific and tissue-specific.
In addition to the chromatin landscape, the environment
of the bound motifs also contributes to motif recognition
by the HD TF. Hox TFs recognize DNA shape in
addition to sequence [24]. Moreover, a comprehensive
analysis of the binding of hundreds of TFs, extracted fromwww.sciencedirect.com
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data, demonstrates distinct sequence compositions for the
environment of the bound motifs. Sites bound by HD TFs
generally have very low GC content around the core
binding site [25]. Interestingly, these preferences can
extend to hundreds of nucleotides outside the core binding
sites, and TFs binding sites tend to be embedded within a
sequence environment with similar characteristics to the
binding motifs. This ‘homotypic environment’ contributes
to the recognition of the cognate binding sites [25]. The
study of Farley et al. [26] offers an additional interpreta-
tion of homotypic environments as a potential source of
suboptimal, low affinity binding sites. Functional enhan-
cers contain imperfect matches to consensus motifs; the
presence of suboptimal recognition motifs attenuates en-
hancer activity, but ensures restricted expression within
specific tissues by preventing ectopic activation in other
tissues. A recent study also provides evidence that subop-
timal binding sites are important for the specificity of aFigure 2
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www.sciencedirect.com Hox-regulated enhancer in Drosophila development [27].
These observations question the importance of optimal
sequence recognition for achieving biological specificity.
An important corollary of these findings is that biologically
relevant sites may be overlooked when searching for
matches to high-affinity sequences identified in silico.
Multiplicity of HD protein-cofactor
interactions on DNA
Once positioned in the genome, HD proteins are able to
interact with many different types of transcriptional part-
ners. Here we do not aim to provide an exhaustive list of
all those interactions, but will rather consider the most
relevant examples to illustrate the different layers on
which animal and plant HD proteins act to control gene
expression (Figure 2).
One layer of activity of HD proteins, which is common
to other types of TFs, is at the level of chromatinPolII 
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ression by HD proteins relies on interactions with specific histone
f DNA-binding proteins (site/tissue-specific TFs, mediator complex
trin 3), and non-coding RNAs (ncRNAs). Interactions result in gene
ltiplicity of HD protein-cofactor interactions on DNA’ for details. HD,
 proteins; PolII, DNA-polymerase II; ncRNAs, non-coding RNAs.
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4 Genome architecture and expressionconformation. For example, it was shown that ANTP
and TALE members could modify the chromatin struc-
ture, either genome wide [20,28] or locally on specific
target genes [29], with a direct incidence on gene
activation or repression. Accordingly, several HD pro-
teins can recognize specific histone modifications, as
described for plant homeodomain (PHD) finger pro-
teins that bind to the H3K4me3 promoter active mark
[30,31]. In addition, HD proteins can modulate the
chromatin structure by directly interacting with chro-
matin remodelling complexes [32,33] or with histone
modifying enzymes such as histone acetyl transferases
[5,34] and histone demethylases [35]. Alternatively, the
interaction between HD proteins and co-activators such
as PTIP [36] or co-repressors such as Groucho [37] can
also indirectly contribute to the recruitment of chroma-
tin remodelling complexes. These remodelling activi-
ties underlie the ability of several HD proteins to
promote reprogramming, as noticed for pioneer factors
in general [11]. HD proteins with reprogramming ac-
tivities, as described for Oct3/4 [38] or Pax7 [39], are
able to bind on closed chromatin and facilitate second-
ary factor binding (of site specific transcription factors
and co-activators) and assembly of active transcriptional
complexes for local gene expression.
Transcriptional activation by HD proteins can also occur
independently of chromatin remodelling activities,
through direct contacts with the mediator complex
[40], direct/indirect interaction with components of the
basal transcription machinery [41,42,43], by recruiting
topoisomerase I [44]. These mechanisms eventually
impact on PolII recruitment or PolII release and tran-
scriptional activation [45].
HD proteins can also recruit ubiquitous and tissue-spe-
cific TFs to drive lineage-specific transcription. For ex-
ample, Crx, a retina-specific HD TF, recruits ubiquitous
MEF2D away from canonical MEF2 binding sites and
redirects it to retina-specific enhancers [46]. Similarly,
Sp7/Osterix, a key regulator of osteoblast specification, is
recruited to osteoblast enhancers by HD TFs of the Dlx
family [47]. In early zebrafish embryogenesis, TALE
HD TFs poise promoters for activation, but efficient
transcription requires subsequent binding of Hox HD
TFs [41]. Along these lines, a recent report suggests that
Hox HD proteins do not activate gene expression by
themselves, but act as transcriptional ‘guarantors’ to pro-
mote full, robust activation of target genes regulated by
other TFs [48]. Because Hox proteins can interact with
many different TFs, as exemplified with Drosophila [49]
and mouse Hox proteins [50], their function as guarantors
may facilitate the activation of target genes by a wide
range of TFs.
The strong interaction plasticity of HD proteins is
also reflected by their capacity to recruit non-proteinCurrent Opinion in Genetics & Development 2017, 43:1–8 molecules such as noncoding RNAs (ncRNAs). These
molecules can be produced from enhancers (called
eRNAs), repeat or intergenic sequences and are now
recognized as critical regulators of gene expression in
development and disease [51]. NcRNAs are described
in several instances to control transcription through chro-
matin remodelling [52,53] and epigenetic modifications
[54,55], but they can also act by modulating the transcrip-
tional activity of HD proteins. The long non-coding RNA
(lncRNA) Evf2 forms complexes with DLX proteins and
increases their transcriptional activities on specific enhan-
cers [56]. More generally, lncRNAs could be important
for the subnuclear organization of factors involved in
transcriptional regulation. The activity of HD proteins
could thus be strongly influenced by their spatial localisa-
tion in the nucleus. Along this line, the transcriptional
activity of Pit1/Pou1f1, a member of the POU class of HD
proteins, depends on its interaction with a complex
composed of the beta-catenin protein and AT-rich bind-
ing factor SATB1. Surprisingly, disrupting Pit1 interac-
tion with beta-catenin/SATB1 complex causes loss of
transcriptional activation, which can be fully rescued
by artificially tethering the mutated Pit1 protein to
matrin-3, a major component of the nuclear matrix
[57]. These findings indicate that HD proteins can
achieve transcriptional specificity by associating with
molecules that control their spatial localisation in the
nucleus.
Taming the high connectivity of HD proteins
The striking interaction plasticity emerging from the
examples above, raises a central question: how can pro-
teins sharing a highly conserved domain (HD) be engaged
in so many diverse context-specific interactions?
The HD constitutes a core DNA-binding, but also a
central protein-protein interaction platform. It is interest-
ing to note that many of the interactions described for the
HD involve other HD proteins from the same or a
different class, that is, Hox–Hox interactions [58] or
PRD-Hox [59], or general co-regulators [60,61]. Although
most of our knowledge on the molecular cues underlying
the regulatory activity of HD TFs relates to the HD itself,
there is an increasing amount of evidence that regions of
the protein surrounding the HD are involved in establish-
ing interactions with tissue-specific and/or context-spe-
cific proteins. In addition to the HD and to conserved,
class-specific domains [1], HD proteins contain less
conserved signatures, including short linear motifs
(SLiMs). SLiMs, which are 5–10 residues long, are typi-
cally involved in weak and transient interactions with
context-specific cofactors [62,63]. SLiMs are often em-
bedded in long disordered regions, a general feature of
TFs and are involved in many different types of inter-
actions [64]. In the case of HD TFs, long disordered
regions have been proposed to be important for context-
specific regulatory activities [65].www.sciencedirect.com
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Molecular mechanisms that limit the interaction potential of HD proteins and increase their specific regulatory function in vivo. The interaction
potential of HD proteins can be limited at the DNA-binding and/or cofactor-binding level by post-translational modifications, mechanisms
regulating the subcellular and subnuclear localisation, the presence of competitive TFs or microproteins (miP), the inhibition in cis from protein
domains and motifs, and potentially in trans by small peptides encoded by small open reading frames (speculative). HD, homeodomain; TF,
transcription factor; miP, microproteins.Together, SLiMs and disordered regions could largely
account for the ability of HD proteins to interact with a
wide range of different and context-specific partners in
vivo, although this remains to be demonstrated in most
cases.
Paradoxically, the presence of long disordered regions,
with their strong interaction potential, challenges the
specificity of HD proteins. Various mechanisms are
deployed to control this strong interaction potential
(Figure 3). The number of contacts established by
HD proteins can be regulated by competitive mecha-
nisms, which displace the HD protein from its DNA
sites [66] or interacting transcriptional partners [67].
Competition can be achieved by proteins and also
microProteins (miPs). MiPs are small proteins often
produced by alternative splicing; they maintain the
interaction interface, but lack a key functional domain
of the HD protein and function like a dominant nega-
tive to form non-functional homo-dimeric or hetero-
dimeric protein complexes [68,69]. Finally, the findings
that HD-deleted [23] or SLiM-mutated  TFs [49]
display aberrant activities and ectopic interactions,
highlight the importance of domains and motifs in
cis for buffering and/or limiting the interaction poten-
tial of HD TFs.www.sciencedirect.com Conclusion and future directions
HD proteins mainly act as TFs that activate or repress
gene expression. The highly conserved HD does not
provide the degree of binding specificity to select func-
tional target genes. For decades of research, this baffling
observation has proved a formidable obstacle to our
understanding of the mechanisms that inform HD TFs
specific functions in vivo. It appears however that a highly
specific binding domain is not as crucial to instruct TFs
binding in vivo as previously thought. Not only is the
chromatin landscape, with its myriad of associated factors,
a major determinant of HD TFs binding in vivo, but
anatomizing biologically active enhancers shows that
arrays of low affinity binding sites could actually do a
better job of establishing tissue-specific transcription than
optimal binding sites. To understand the determinants of
specificity, that is, how each HD TF selects and regulates
a specific set of target genes relative to other HD class
members, the focus is shifting from the capacity to
establish highly specific interactions with DNA to the
ability to interact with and recruit diverse, context-spe-
cific molecules. The examples reported in this review,
although by no means comprehensive, reveal a dazzling
array of strategies employed by HD TFs to control gene
expression. The emerging, unifying theme is the ability
of HD TFs to interact with many diverse partners. ThisCurrent Opinion in Genetics & Development 2017, 43:1–8
6 Genome architecture and expressionhigh connectivity is probably crucial to assemble highly
context-specific, transcriptionally active complexes at
selected sites in the genome. In this respect, the relatively
low DNA binding specificity conferred by the HD may
allow HD TFs to contact DNA at many sites and there-
fore establish tripartite interactions involving DNA and a
diverse array of other DNA-binding TFs in vivo.
High-throughput studies have enabled genome-wide and
proteome-wide mapping of HD TFs binding. However
many studies have been conducted in vitro or in cell lines
and are unlikely to capture the highly dynamic regulatory
output of HD TFs in space and time. Now functional
analyses are required to provide the mechanistic insight
into how HD TFs work, in their native, tissue-specific
and/or cell-specific expression domains, and at the reso-
lution level of specific targets. This will be facilitated by
single cell approaches and also development of cutting-
edge tools that will allow purifying protein complexes in a
cell-specific and promoter-specific manner in the future.
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